LATE OF Riga, undefined

Gustav Yanovich Vanags, Deceased

This inventor holds 1 USPTO granted patent. Top assignee: Institut Organicheskogo Sinteza. Active years: 1976.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gustav Yanovich Vanags, Deceased. Retrieved from https://idiyas.com/inventor/gustav-yanovich-vanags-deceased

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gustav Yanovich Vanags: A Legacy in Antiepileptic Compounds

Introduction

Gustav Yanovich Vanags was a notable inventor known for his contributions to the field of medicinal chemistry. He was particularly recognized for his work on antiepileptic compounds. His innovative spirit and dedication to research left a lasting impact on the scientific community.

Latest Patents

Vanags held a patent for a methylamino derivative of 2-ethylindandione-1,3 and its hydrochloride. This patent, which is classified as an antiepileptic compound, is represented by the formula: ##EQU1## wherein R is --NHCH.sub.3, --NHC.sub.2 H.sub.5, and the hydrochlorides thereof. His work in this area has contributed to advancements in the treatment of epilepsy.

Career Highlights

Throughout his career, Vanags was associated with the Institut Organicheskogo Sinteza, where he conducted significant research. His dedication to the field of organic synthesis and medicinal chemistry was evident in his innovative approaches to drug development.

Collaborations

Vanags collaborated with several notable scientists, including Yan-Voldemar Y Ozol and Avgust Karlovich Aren. These collaborations fostered a rich environment for scientific inquiry and innovation.

Conclusion

Gustav Yanovich Vanags' contributions to the field of antiepileptic compounds have left a significant mark on medicinal chemistry. His legacy continues to inspire future generations of inventors and researchers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…